Literature DB >> 31347706

A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family.

Lianqing Wang1, Xinchao Bian2, Guangying Cheng3, Peiqing Zhao1, Xinxin Xiang1, Wenxiu Tian1, Tao Li1, Qiaoli Zhai1.   

Abstract

Osteoporosis is a complex bone metabolic disorder. Genetic factors play an important role in the development of osteoporosis. Mutations in more than 15 genes have been identified to be responsible for osteoporosis to date. Most recently, the gene PLS3 encoding plastin 3 was recognized to be involved in X-linked osteoporosis. Here, we recruited a four-generation Chinese family with X-linked osteoporosis, which had its onset in childhood and was characterized by peripheral fractures and low bone mineral density. All affected individuals shared a nonsense variant (c.244C > T) in exon 4 of PLS3 on Xq23. The variant in affected individuals segregated with the osteoporosis phenotype. By restriction analysis using Dra I, this variant was confirmed in all affected individuals but was not detected in unaffected family members or in 100 unrelated Chinese male controls. The variant was predicted to cause a premature termination of messenger RNA (mRNA) translation (p.Gln82*). The mutant mRNA degraded via the mechanism of "nonsense-mediated mRNA decay." In the present study, we identified a novel nonsense variant of PLS3 in early-onset X-linked osteoporosis and provided a novel insight into the molecular mechanism underlying the pathogenesis of osteoporosis.
© 2019 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  PLS3; X-linked osteoporosis; c.244C > T; nonsense

Mesh:

Substances:

Year:  2019        PMID: 31347706     DOI: 10.1111/ahg.12344

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

1.  Osteogenesis imperfecta mutations in plastin 3 lead to impaired calcium regulation of actin bundling.

Authors:  Christopher L Schwebach; Elena Kudryashova; Weili Zheng; Matthew Orchard; Harper Smith; Lucas A Runyan; Edward H Egelman; Dmitri S Kudryashov
Journal:  Bone Res       Date:  2020-05-22       Impact factor: 13.567

Review 2.  Plastin 3 in health and disease: a matter of balance.

Authors:  Lisa Wolff; Eike A Strathmann; Ilka Müller; Daniela Mählich; Charlotte Veltman; Anja Niehoff; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2021-05-23       Impact factor: 9.261

3.  Osteogenesis imperfecta mutations in plastin 3 lead to impaired calcium regulation of actin bundling.

Authors:  Christopher L Schwebach; Elena Kudryashova; Weili Zheng; Matthew Orchard; Harper Smith; Lucas A Runyan; Edward H Egelman; Dmitri S Kudryashov
Journal:  Bone Res       Date:  2020-05-22       Impact factor: 13.567

4.  A novel mutation in PLS3 causes extremely rare X-linked osteogenesis imperfecta.

Authors:  Jing Hu; Lu-Jiao Li; Wen-Bin Zheng; Di-Chen Zhao; Ou Wang; Yan Jiang; Xiao-Ping Xing; Mei Li; Weibo Xia
Journal:  Mol Genet Genomic Med       Date:  2020-11-09       Impact factor: 2.183

Review 5.  Plastin 3 in X-Linked Osteoporosis: Imbalance of Ca2+-Dependent Regulation Is Equivalent to Protein Loss.

Authors:  Christopher L Schwebach; Elena Kudryashova; Dmitri S Kudryashov
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 6.  Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.

Authors:  Lucia Oton-Gonzalez; Chiara Mazziotta; Maria Rosa Iaquinta; Elisa Mazzoni; Riccardo Nocini; Lorenzo Trevisiol; Antonio D'Agostino; Mauro Tognon; John Charles Rotondo; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

7.  Expression and Localization of Thrombospondins, Plastin 3, and STIM1 in Different Cartilage Compartments of the Osteoarthritic Varus Knee.

Authors:  Daniela Mählich; Anne Glasmacher; Ilka Müller; Johannes Oppermann; David Grevenstein; Peer Eysel; Juliane Heilig; Brunhilde Wirth; Frank Zaucke; Anja Niehoff
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

8.  X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in PLS3.

Authors:  Petar Brlek; Darko Antičević; Vilim Molnar; Vid Matišić; Kristina Robinson; Swaroop Aradhya; Dalibor Krpan; Dragan Primorac
Journal:  Genes (Basel)       Date:  2021-11-23       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.